Lodestar

LTGO

Latigo Biotherapeutics, Inc.
NasdaqPharmaceutical PreparationsLatest fiscal year ended Dec 31, 2025

Figures below are compared against other companies classified under Pharmaceutical Preparations.

Grades vs. industry

No grades available. Grades compare a company against others sharing its industry classification, and this one does not have enough classified peers with reported figures to support a meaningful comparison.

Financial health

MetricCompanyIndustry medianRank
Debt to equity
Total debt divided by shareholder equity.
Not reported0.24x—
Current ratio
Current assets over current liabilities.
4.00x4.17x218 / 419
Quick ratio
Current assets excluding inventory, over current liabilities.
4.00x3.84x206 / 419
Interest coverage
Operating income divided by interest expense.
Not reported-15.21x—
Net debt to EBITDA
Net debt over derived EBITDA. EBITDA is not a GAAP tag; it is computed.
Not reported-1.56x—

top third of peersmiddle thirdbottom third. Rank 1 is always best — for debt and payout ratios that means the lowest figure, not the highest.

“Not reported” means the company did not tag this figure in its filing, not that the value is zero. Rankings are hidden where fewer than 5 classified peers reported the metric, and compare against a broad industry code rather than close competitors.

Insider activity

Trades reported by officers, directors and 10% shareholders on SEC Form 4. 2 of the last 40 reported transactions were open-market purchases; the rest are mostly sales and compensation.

DateInsiderTransactionSharesPriceValue
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Open-market purchase140,000$18.00$2.52M
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Open-market purchase140,000$18.00$2.52M
Aug 10, 2026
5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, PARMAR KUSH, Schwab Andrew J.
10% owner
Conversion(derivative)3,152,305$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion3,117,664$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion296,880$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)3,117,664$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)445,320$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)1,125,823$0.00$0.00
Aug 10, 2026
5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, PARMAR KUSH, Schwab Andrew J.
10% owner
Conversion(derivative)1,823,238$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion1,125,823$0.00$0.00
Aug 10, 2026
5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, PARMAR KUSH, Schwab Andrew J.
10% owner
Conversion(derivative)866,018$0.00$0.00
Aug 10, 2026
5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, PARMAR KUSH, Schwab Andrew J.
10% owner
Conversion(derivative)1,484,401$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion3,117,664$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion445,320$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)3,117,664$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)296,880$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion(derivative)742,201$0.00$0.00
Aug 10, 2026
Foresite Capital Management V, LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP
10% owner
Conversion742,201$0.00$0.00
Aug 10, 2026
SEIDENBERG BETH C
Director, 10% owner
Conversion(derivative)165,519——
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Conversion3,117,664——
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Conversion445,320——
Aug 10, 2026
Sanofi
10% owner
Conversion494,800——
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Conversion742,201——
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Conversion195,776——
Aug 10, 2026
Tananbaum James B.
Director, 10% owner
Conversion3,117,664——

A dash under price or value means none was reported, which is normal for grants and gifts — it does not mean the shares were free. Option exercises and awards are compensation arriving on a schedule, not a judgement about the stock.

Annual financials

Fiscal year2026
Total assets$75.52M
Shareholder equity-$231.67M
Cash$69.44M
Dividends per share$0.00

A dash means the figure was not tagged in that year’s filing. It does not mean zero. Figures reflect the most recent filing covering each period, so restated years show their restated values.

Source

Figures come from Latigo Biotherapeutics, Inc.’s filings with the SEC, as submitted in XBRL. The most recent annual figures are from a 10-Q filed Sep 3, 2026. View filings on EDGAR.

Not financial advice. This page presents figures reported to the SEC and compares them with other companies sharing an industry classification. It is not a recommendation to buy or sell anything, and the grades cannot capture everything that matters about a business. Industry classifications are coarse, filings are self-reported, and some figures are missing or understated where companies tag them in ways this site does not match. Do your own research.